Capstone Investment Advisors, LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $409,635 - $480,704	400 Added 19.05%	2,500 $2.63 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $1.15 Million - $1.39 Million	1,300 Added 162.5%	2,100 $2.21 Million
Q1 2024 May 01, 2024	SELL	$902.69 - $993.35 $1.26 Million - $1.39 Million	-1,400 Reduced 63.64%	800 $769,000
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $542,626 - $617,190	700 Added 46.67%	2,200 $1.93 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $69,245 - $84,437	100 Added 7.14%	1,500 $1.23 Million
Q1 2023 May 09, 2023	SELL	$680.49 - $826.97 $476,343 - $578,879	-700 Reduced 33.33%	1,400 $1.15 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $114,794 - $144,864	200 Added 10.53%	2,100 $1.45 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $1.65 Million - $2.22 Million	-3,000 Reduced 61.22%	1,900 $1.12 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $6.67 Million - $7.82 Million	-11,200 Reduced 69.57%	4,900 $3.42 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $1.03 Million - $1.27 Million	-1,900 Reduced 10.56%	16,100 $10.2 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $2.81 Million - $3.34 Million	4,900 Added 37.4%	18,000 $10.9 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $1.51 Million - $1.79 Million	3,200 Added 32.32%	13,100 $7.32 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $1.34 Million - $1.64 Million	3,000 Added 43.48%	9,900 $4.68 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $669,620 - $851,172	-1,400 Reduced 16.87%	6,900 $3.33 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $2.67 Million - $3.23 Million	4,900 Added 144.12%	8,300 $4.65 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $295,992 - $386,352	-600 Reduced 15.0%	3,400 $2.12 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $8.3 Million - $12.2 Million	-24,700 Reduced 86.06%	4,000 $1.95 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $1.23 Million - $1.69 Million	-4,500 Reduced 13.55%	28,700 $10.8 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $2.38 Million - $2.77 Million	-8,700 Reduced 20.76%	33,200 $9.21 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $2.82 Million - $3.9 Million	9,400 Added 28.92%	41,900 $13.1 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $11.8 Million - $13.9 Million	31,600 Added 3511.11%	32,500 $13.3 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $201,492 - $241,824	600 Added 200.0%	900 $336,000
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $105,342 - $122,553	300 New	300 $121,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account